Biotechnology BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference December 28, 2022
Health Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-1811 From Jounce Therapeutics December 27, 2022
Biotechnology Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference December 27, 2022